Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Metirra Pty Ltd. has 1 pending office action in Chemistry & Materials. The matter is assigned to 1 distinct examiner and 1 distinct art unit, showing a concentrated examination path. GZYBOWSKI, MICHAEL STANLEY is the busiest examiner, with 1 pending matter.
The profile supports a focused review of one outstanding chemistry and materials action. No additional examiner or art-unit assignment is recorded, so counsel can develop a single coordinated response strategy. Claim scope, technical evidence, and disclosure support should be aligned to the issues before the identified examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GZYBOWSKI, MICHAEL STANLEY | 1 | 67.6% | +52.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17762517 | METHODS FOR CONFIRMING DETECTION AND EVALUATING THE PROGRESSION OF A PROSTATE CANCER AND RELATED THERAPIES | GZYBOWSKI, MICHAEL STANLEY | 35d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17762517 | METHODS FOR CONFIRMING DETECTION AND EVALUATING THE PROGRESSION OF A PROSTATE CANCER AND RELATED THERAPIES | GZYBOWSKI, MICHAEL STANLEY | 35d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17762517 | METHODS FOR CONFIRMING DETECTION AND EVALUATING THE PROGRESSION OF A PROSTATE CANCER AND RELATED THERAPIES | GZYBOWSKI, MICHAEL STANLEY | 1798 | §101§103§112 | Final Rejection | 35d overdue | Pending | Mar 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMetirra Pty Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael Stanley Gzybowski has the most, with 1 of Metirra Pty Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
